v3.26.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Current Assets    
Cash and cash equivalents $ 88 $ 2,873
Accounts receivable, net 155 70
Inventories 86 33
Prepaid expenses and other current assets 61 316
Total current assets 390 3,292
Property and equipment, net 64 91
Operating lease right-of-use assets, net 162 105
Intangible assets, net 15,236 24,274
Other non-current assets 8 8
TOTAL ASSETS 15,860 27,770
Current Liabilities    
Accounts payable 1,492 230
Accrued expenses 1,697 1,548
Convertible notes payable, at fair value 298 0
Current portion of operating lease liabilities 63 98
Total current liabilities 3,907 2,230
Royalties payable due to related parties 792 9,068
Operating lease liabilities 101 13
Deferred tax liability 1,331 3,141
Total liabilities 9,209 16,013
Commitments and Contingencies (see Note 16)
Stockholders' Equity    
Common stock, $0.0001 par value, 500,000,000 shares authorized; 1,738,955 and 421,296 shares issued and outstanding as of December 31, 2025 and December 31, 2024, respectively 0 0
Additional paid-in capital 316,589 304,109
Accumulated deficit (309,535) (292,352)
Total stockholders' equity attributable to Catheter Precision, Inc. 7,054 11,757
Non-controlling interest (403) 0
Total stockholders' equity 6,651 11,757
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY 15,860 27,770
Series A Preferred Stock [Member]    
Stockholders' Equity    
Preferred Stock 0 0
Series B Preferred Stock [Member]    
Stockholders' Equity    
Preferred Stock 0 0
Series J Preferred Stock [Member]    
Stockholders' Equity    
Preferred Stock 0 0
Series X Preferred Stock [Member]    
Stockholders' Equity    
Preferred Stock 0 0
Nonrelated Party [Member]    
Current Liabilities    
Short-term notes payable 0 177
Notes payable of variable interest entities, net of discount 1,330 0
Related Party [Member]    
Current Liabilities    
Short-term notes payable of variable interest entities due to related parties 306 0
Current portion of royalties payable due to related parties 51 177
Notes payable of variable interest entities, net of discount $ 1,748 $ 1,561